NCT02484768View on ClinicalTrials.gov

IV Iron Treatment of Restless Legs Syndrome

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Restless Legs Syndrome
Interventions
DRUG

Iron isomaltoside 1000

Intravenous treatment

DRUG

Sodium Chloride 0.9%

Intravenous treatment

Sponsors

Lead Sponsor

Pharmacosmos A/S

Collaborators (1)

BioStata
All Listed Sponsors
collaborator

BioStata

INDUSTRY

collaborator

Laboratory Corporation of America

INDUSTRY

lead

Pharmacosmos A/S

INDUSTRY